Html code here! Replace this with any non empty raw html code and that's it.

Study finds weight-loss drugs may support heart recovery after heart attack

Date:

Share this article:

Del denne artikel:

New research suggests popular weight-loss drugs may help the heart recover after a heart attack.

Weight-loss injections have become some of the most talked-about medicines in recent years.

Many people recognize the names from headlines about diabetes treatment and dramatic weight loss.

But scientists are now uncovering a possible benefit that has little to do with the number on the scale. The same medications may also help the heart recover after a heart attack.

A new discovery

Researchers from the University of Bristol and University College London have been studying a group of drugs known as GLP-1 medications. These include treatments widely used for obesity and type 2 diabetes.

Also read: Analysis of 124,837 people: Aspirin provides no reliable protection against colorectal cancer

Their findings, published in the journal Nature Communications, suggest the drugs may improve blood circulation inside the heart after a heart attack.

Even when doctors quickly reopen a blocked artery during emergency treatment, problems can remain.

The smallest blood vessels in the heart sometimes stay narrowed, preventing oxygen-rich blood from reaching damaged tissue.

The tiny vessels

The research team focused on small cells called pericytes. These cells surround the heart’s smallest capillaries and control how wide the vessels are.

Also read: Diabetes and weight-loss drugs may reduce risk of substance use, study finds

During a heart attack, a lack of oxygen can cause these cells to tighten. When that happens, the tiny vessels constrict and blood struggles to flow through the heart muscle.

Experiments showed that GLP-1 drugs appear to relax these cells. The medications activate potassium channels that help the vessels open again, allowing circulation to improve.

Why it matters

Better blood flow in these microvessels could help limit damage after a heart attack and support the heart’s recovery.

Researchers say the findings are particularly promising because these medications are already widely used around the world.

Also read: New discovery could lead to future malaria treatments

Possible benefits highlighted by the study include:

  • improved circulation in damaged heart tissue
  • reduced risk of complications after a heart attack
  • better long-term recovery for patients

Further studies involving human patients will be needed before doctors can confirm whether the same effects appear in clinical treatment.

Sources: Science Daily and Nature

Also read: Seven snacks that could be draining your energy

Also read: Debate emerges after doctor criticizes health impact of bananas

Other articles

Experts warn about three possible signs of prostate cancer during bathroom visits

A type of cancer can develop for years without clear symptoms. This means many people may not notice...

Analysis of 124,837 people: Aspirin provides no reliable protection against colorectal cancer

Many people take aspirin daily to protect their health. However, new research suggests that its effect against colorectal cancer is uncertain.

Diabetes and weight-loss drugs may reduce risk of substance use, study finds

GLP-1 medications, widely known for treating diabetes and obesity, are now being investigated for a completely different potential effect.

New discovery could lead to future malaria treatments

An international team of researchers has investigated how the malaria parasite reproduces. The findings could have implications for the development of future medicines.

Experts warn about three possible signs of prostate cancer during bathroom visits

A type of cancer can develop for years without clear symptoms. This means many people may not notice...

Analysis of 124,837 people: Aspirin provides no reliable protection against colorectal cancer

Many people take aspirin daily to protect their health. However, new research suggests that its effect against colorectal cancer is uncertain.

Diabetes and weight-loss drugs may reduce risk of substance use, study finds

GLP-1 medications, widely known for treating diabetes and obesity, are now being investigated for a completely different potential effect.